Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as ...
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of diseases and adverse health ...
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...
There’s a virus rapidly circulating through much of the South, Centers for Disease Control and Prevention data show – and ...
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...
Treat the symptoms: First, isolate from others as much as possible. Slow down stool with anti-diarrheal medication and drink ...
The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...
A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.
Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...
Health officials are raising alarms about a significant increase in norovirus cases nationwide, including here in North Texas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback